• Scientific rationale

    Thanks to the participation of a panel of nationally and internationally renowned speakers, the meeting aims to:

    • Expanding participants’ knowledge about clinical indications and advantages of hadrontherapy in an international overview and perspectives
    • Informing participants on managerial, technical and clinical aspect of an hadrontherapy facility 
    • Improving understanding on resource requirements, challenges, economical and social implications of hadrontherapy
    • Presenting status and perspectives of a new research clinical modality, BNCT (Boron Neutron Capture Therapy)

  • Programme

    09:00Participant Registration
    09:30Welcome Addresses

    SESSION 1: CLINICAL ACTIVITIES    		Moderatore: Lisa Francesca Linda Licitra
    09:45Keynote lecture Historical and scientific evolution of hadrontherapyUgo Amaldi
    10:15Hadrontherapy in the context of cancer care in ItalyMarco Krengli
    10:35Hadrontherapy vs X-ray therapy: clinical aspects, patient pathway and clinical QA considerations

    Clinical indications:    		Ester Orlandi
    10:55Chordoma and ChondrosarcomaPiero Fossati
    11:15Coffee Break
    11:30Head and Neck cancersBarbara Vischioni
    11:50Central Nervous System tumorsSemi Harrabi
    12:10Gastroenteric and gynaecological tumorsAmelia Barcellini
    12:30Pediatric cancersSabina Vennarini
    12:50Heavy ions for prostate cancer: how to manage pelvic nodes?Mack Roach
    13:10Lunch
    SESSION 2: CLINICAL ACTIVITIESModeratore: Mario Ciocca
    14:30Clinical research and future prospectiveRoberto Orecchia
    14:50Patient clinical workflow including image guidanceGuido Baroni
    15:10Treatment planning: comparing techniques and standardsSilvia Molinelli
    15:30Clinical dosimetry and quality assuranceStefano Lorentini
    15:50Coffee Break
    16:05Radiobiology: current trend and future prospectiveMicheal Story
    16:25Novel approaches in particle therapyAndrea Mairani
    16:45Implementing a carbon ion facility: the Mayo Clinic ProjectLaura Vallow
    19:30Social Event
    SESSION 3: HEALTH POLICY CONTEXT AND HEALTH ECONOMICS OF HADRON THERAPYModeratore: Andrea Riccardo Filippi
    09:00ENLIGHT (European Network for Light Ion Hadron Therapy) and its role in Hadron TherapyManjit Dosanjh
    09:20Academia meets Industry: IP, communication, managing expectationsManuela Cirilli
    09:40Funding and health economicFabio Michele Amatucci
    10:00Financial toxicity: PSI experienceBarbara Bachtiary
    10:20CNAO: cost benefit AnalysisMaria Vittoria Livraga
    10:40Coffee Break
    SESSION 4: ORGANIZATION AND OPERATION OF MULTI PARTICLE THERAPY FACILITYModeratore: Marco Cianchetti
    11:00The Heidelberg Ion Beam Therapy Center - Technology, Clinical Application and ResearchThomas Haberer
    11:20The CNAO facility: operation and maintenanceGiuseppe Venchi
    11:40The MedAustron facilityMauro Torino Francesco Pivi
    12:00The Marburg facilityKlemens Zink
    12:20New accelerator designs: NIMMSMaurizio Vretenar
    12:40The vision of the SEEIIST projectLeander Litov
    13:00Carbon facilities outside Europe with focus on USA/NCI programmeArnold Pompos
    13:20Lunch
    SESSION 5: RESEARCH & DEVELOPMENT IN HADRONTHERAPYModeratore: Giuseppe Antonio Pablo Cirrone
    14:30Building capacity through the IAEA programsSotirios Charisopoulos
    14:50HITRIplus project overviewAngelica Facoetti
    15:10Imaging: current trends and future perspectivesKatia Parodi
    15:30Flash Therapy with light ionsEmanuele Scifoni
    15:50Coffee Break
    16:05Upright positioning and arc therapyChristian Graeff
    16:25New Gantry for ionsMarco Giuseppe Pullia
    16:45New technologies: superconducting magnetsErnesto De Matteis
    17:05Discussion
    17:30Visit of CNAO
    BNCT: SESSION 1
    Chair: Saverio Altieri – Paolo Pedrazzoli
    09:00Hadron therapy in radiation oncology and why BNCT is a paradigm shiftWolfgang Sauerwein
    09:20Clinical BNCT experience with acceleratorsMinoru Suzuki
    09:40BNCT clinical trialsPeeter Karihtala
    10:00Progress to clinical adoption of accelerator based BNCTLisa Licitra
    10:20Development of new novel BNCT drugsKendall Morrison
    10:40Online boron dose distribution imagingNicoletta Protti
    11:00Coffee break
    BNCT: SESSION 2
    Chair: Valerio Vercesi – Barbara Croesi
    11:20Radiobiological characterization of a BNCT beamMitsuko Masutani
    11:40Dosimetry in BNCTStuart Green
    12:00Micro-dosimetry of a neutron BNCT beamValeria Conte
    12:20Treatment planning for BNCTIan Postuma
    12:40Discussion
    13:00Lunch
    BNCT: SESSION 3
    Chair: Stefano Agosteo – Laura Locati
    14:00Structural basis of cancer cells uptake of boronated compoundsVittorio Bellotti
    14:20Accelerator based neutron sources for BNCTAndres Kreiner
    14:40Development of the IAEA publication ‘Advances in Boron Neutron Capture TherapyIan Swainson
    15:00BNCT@CNAOSandro Rossi
    15:20Discussion and closing remarks
    15:40Visit of LENA

  • How to participate the meeting

    Enrollment can be performed exclusively through the online procedure, new registration at the congress venue will not be accepted.

  • Registration

    This course is reserved to a limited number of participants.

    Participation in this course is free of charge.

    Completing the online registration is mandatory to attend this course.

  • CME Instructions

    To obtain CME credits, users must meet the following requirements:

    1. Their declared profession/specialization must correspond to those accredited for CME.
    2. They must attend at least 90% of the course.
    3. They must complete the online meeting evaluation form.
    4. They must pass the learning assessment test with at least 75% correct answers. Only one attempt is allowed.

    The learning assessment test and meeting evaluation form must be submitted within three days of the event.

    Please note that in order to access the learning assessment test, users must (A) register at the course venue and (B) submit the online meeting evaluation form.

    Certificate of attendance 
    To download the certificate of attendance, users must have registered at the course venue.
    If their attendance is less than 75% of the stated duration, the certificate will reflect the percentage of attendance.
    We strongly encourage users to keep track of their personal badge and the badge recordings by the AccMed personnel, it is users' responsibility to have their attendance recorded accurately.


  • Training objective

    Contenuti tecnico-professionali (conoscenze e competenze) specifici di ciascuna professione, di ciascuna specializzazione e di ciascuna attività ultraspecialistica, ivi incluse le malattie rare e la medicina di genere

  • Quality Report